Bavarian Nordic Research Institute A/S, Vaccine Solutions Pty. Ltd. deal

BNRI received exclusive global rights to Vaccine Solutions’s Polytope technology for use in BNRI’s epitope-based HIV vaccine. BNRI will merge the technology with its MVA-BN vector. Polytope allows t...